Loading
Latest filing published 07 Jul 2021 for Cell Source, Inc., €3,074. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of David Zolty in Cell Source, Inc., where the filings describe the role as board member. In total, 2 filings cover trades dated from 4 December 2017 to 30 June 2021.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 7 July 2021, reports a transaction of €3,074 in Cell Source, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations